Circulating Tumor Cell Testing Market Leading Player 2022-28
Submitted by sayabugari bhavana | December 21, 2022, 12:17:59 | Health
Circulating Tumor Cell (CTC) Testing Market size was valued at USD 9.4 billion in 2021 and is expected to reach USD 16.4 billion by 2028, at a CAGR of 11.7% during the forecast period 2022-2028. Circulating Tumor Cell (CTC) Testing is a simple blood test that helps oncologists to assess the prognosis of patients with metastatic colorectal, breast, or prostate cancer.
Source: https://precisionbusinessinsights.com/market-reports/circulating-tumor-cell-ctc-testing-market/
